Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Molenaar de Backer, Marijke W A ^a   Lukashov, Vladimir V ^b   van Binnendijk, Rob S ^c   Boot, Hein J ^c   Zaaijer, Hans L ^a,b  

^a CENTRAL LABORATORY   (Netherlands)

^b Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; CHILD; CONTROLLED STUDY; ERYTHEMA INFECTIOSUM; ETHNIC GROUP; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINE; GENETIC VARIABILITY; HUMAN; HUMAN PARVOVIRUS B19; HUMAN PARVOVIRUS B19 1A1; HUMAN PARVOVIRUS B19 1A2; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; SPECIES COEXISTENCE; SPECIES DISTRIBUTION; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS STRAIN;

BASE SEQUENCE; BIOLOGICAL EVOLUTION; CLUSTER ANALYSIS; DEMOGRAPHY; DNA PRIMERS; ERYTHEMA INFECTIOSUM; GENOME, VIRAL; GENOTYPE; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NETHERLANDS; PARVOVIRUS B19, HUMAN; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY;

EID: 84865057687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043206     Document Type: Article

References (33)

1. Servant-Delmas A, Lefrere JJ, Morinet F, Pillet S, ((2010)) Advances in human B19 erythrovirus biology. J Virol 84:: 9658--9665.
2. Brown KE, Young NS, Liu JM, ((1994)) Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 16:: 1--31.
3. Brown KE, Anderson SM, Young NS, ((1993)) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:: 114--117.
4. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, et al. ((2005)) Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106:: 3449--3456. 2005-02-0536 [pii];10.1182/blood-2005-02-0536 [doi].
5. Weigel-Kelley KA, Yoder MC, Srivastava A, ((2003)) Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102:: 3927--3933.
6. Morita E, Sugamura K, ((2002)) Human parvovirus B19-induced cell cycle arrest and apoptosis. Springer Semin Immunopathol 24:: 187--199.
7. von PA, Gigler A, Lang B, Wolf H, Modrow S, ((1995)) Antibodies to parvovirus B19 NS-1 protein in infected individuals. J Gen Virol 76 (Pt3):: 519--527.
8. Nunoue T, Okochi K, Mortimer PP, Cohen BJ, ((1985)) Human parvovirus (B19) and erythema infectiosum. J Pediatr 107:: 38--40.
9. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR, ((1986)) Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 58:: 921--936.
10. Fauquet, C M., Mayo, M A., Maniloff J., Desselberger U., and Ball, L A. (2005) Virus Taxonomy: VIIIth Report of the ICTV. Elsevier/Academic Press London.
11. Servant A, Laperche S, Lallemand F, Marinho V, De Saint MG, et al. ((2002)) Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76:: 9124--9134.
12. Suzuki M, Yoto Y, Ishikawa A, Tsutsumi H, ((2009)) Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008. J Virol 83:: 10975--10980.
13. Zaaijer HL, Koppelman MH, Farrington CP, ((2004)) Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect 132:: 1161--1166.
14. Kooistra K, Mesman HJ, de Waal M, Koppelman MH, Zaaijer HL, ((2011)) Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009. Vox Sang 100:: 261--266.
15. Koppelman MH, Rood IG, Fryer JF, Baylis SA, Cuypers HT, ((2007)) Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays. Vox Sang 93:: 208--215.
16. Koppelman MH, van Swieten P, Cuijpers HT, ((2011)) Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay. Transfusion 51:: 1346--1354.
17. Hokynar K, Brunstein J, Soderlund-Venermo M, Kiviluoto O, Partio EK, et al. ((2000)) Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 81:: 1017--1025.
18. van Hemert FJ, Berkhout B, Lukashov VV, ((2007)) Host-related nucleotide composition and codon usage as driving forces in the recent evolution of the Astroviridae. Virology 361:: 447--454. S0042-6822(06)00872-5 [pii];10.1016/j.virol.2006.11.021 [doi].
19. Parsyan A, Candotti D, ((2007)) Human erythrovirus B19 and blood transfusion- an update. Transfus Med 17:: 263--278.
20. Sato H, Hirata J, Kuroda N, Shiraki H, Maeda Y, et al. ((1991)) Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies. J Virol 65:: 5485--5490.
21. Mori J, Beattie P, Melton DW, Cohen BJ, Clewley JP, ((1987)) Structure and mapping of the DNA of human parvovirus B19. J Gen Virol 68 (Pt 11):: 2797--2806.
22. Umene K, Nunoue T, ((1990)) The genome type of human parvovirus B19 strains isolated in Japan during 1981 differs from types detected in 1986 to 1987: a correlation between genome type and prevalence. J Gen Virol 71 (Pt 4):: 983--986.
23. Morinet F, Tratschin JD, Perol Y, Siegl G, ((1986)) Comparison of 17 isolates of the human parvovirus B 19 by restriction enzyme analysis. Brief report. Arch Virol 90:: 165--172.
24. Umene K, Nunoue T, ((1991)) Genetic diversity of human parvovirus B19 determined using a set of restriction endonucleases recognizing four or five base pairs and partial nucleotide sequencing: use of sequence variability in virus classification. J Gen Virol 72 (Pt 8):: 1997--2001.
25. Lukashov VV, Goudsmit J (2001) Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J Virol 75: 2729-2740. 10.1128/JVI.75.6.2729-2740.2001 [doi].
26. Kryazhimskiy S, Plotkin JB (2008) The population genetics of dN/dS. PLoS Genet 4: e1000304. 10.1371/journal.pgen.1000304 [doi].
27. Aurora R, Donlin MJ, Cannon NA, Tavis JE (2009) Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans. J Clin Invest 119: 225-236. 37085 [pii];10.1172/JCI37085 [doi].
28. Barroso H, Borrego P, Bartolo I, Marcelino JM, Familia C,et al. (2011) Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection. PLoS One 6: e14548. 10.1371/journal.pone.0014548 [doi].
29. van Hemert FJ, Berkhout B, Lukashov VV (2007) Host-related nucleotide composition and codon usage as driving forces in the recent evolution of the Astroviridae. Virology 361: 447-454. S0042-6822(06)00872-5 [pii];10.1016/j.virol.2006.11.021 [doi].
30. Berkhout B, Grigoriev A, Bakker M, Lukashov VV (2002) Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. AIDS Res Hum Retroviruses 18: 133-141. 10.1089/08892220252779674 [doi].
31. Zsiros J, Jebbink MF, Lukashov VV, Voute PA, Berkhout B, ((1999)) Biased nucleotide composition of the genome of HERV-K related endogenous retroviruses and its evolutionary implications. J Mol Evol 48:: 102--111.
32. Lin CL, Kao JH (2011) The clinical implications of hepatitis B virus genotype: Recent advances. J Gastroenterol Hepatol 26 Suppl 1: 123-130. 10.1111/j.1440-1746.2010.06541.x [doi].
33. Baylis SA, Shah N, Minor PD, ((2004)) Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J Virol Methods 121:: 7--16.